Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Director's Dealing 2019

Feb 15, 2019

1643_dirs_2019-02-15_ad2f317f-cdad-434c-94f3-a26e7e1bf7de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MyoKardia Inc (MYOK)
CIK: 0001552451
Period of Report: 2019-02-13

Reporting Person: Sanofi (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-13 Common Stock (par value $0.0001) S 4168899 $37.66 Disposed 0 Indirect

Footnotes

F1: On February 13, 2019, the reporting person sold 4,168,899 shares of MYOK at a price of $37.66 (the "Transaction"). As a result of the Transaction, the reporting person no longer owns shares of common stock of MYOK and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of MYOK.